Table 3 Secondary clinical outcomes in 150 patients after randomization
Source, n (%) | Following randomization: total N = 150 |
|---|---|
Blood culture positive | 29 (19.3) |
Intra-abdominal infection | 5 (3.3) |
Urinary culture positive | 19 (12.7) |
Skin or soft tissue infection | 6 (4.0) |
Lactobacillus species cultured from sterile site | 1 (0.7) |
Diarrhea (≥3 stools/day) | 110 (73.3) |
Antibiotic-associated diarrhea | 95 (63.3) |
Clostridium difficile infection | 2 (1.3) |